Customised Oocyte Donation Enhancement and New Findings Regarding the Role of Growth Hormone

European Medical Journal Reproductive Health

article

Jan Tesarik¹ 

[1] MARGen Clinic

关键词: Customised protocol;    endometrium;    growth hormone (GH);    implantation;    oocyte donation;    uterus;   

DOI  :  10.33590/emj/10313812

学科分类：经济地理

来源: European Medical Journal

【 摘 要 】

In vitro fertilisation (IVF) with donated oocytes is the most effective assisted reproduction treatment currently available; however, repeated implantation failure (RIF) can occur with this treatment. The protocol of patient preparation for IVF with donated oocytes is relatively simple and works well in most cases; however, it can fail in a minority of women, which is what occurs in RIF patients. While the probability of RIF occuring is 20–35%, it is reasonable to take adequate measures in all patients in order to avoid procedural failure. The risk of oocyte donation failure can be minimised by applying a customised oocyte donation enhancement (CODE) protocol, in which pitfalls of the standard protocol are detected and corrected in the pretreatment phase, during the patient’s uterus preparation for embryo transfer, and after the transfer. Growth hormone, recently reported to improve pregnancy outcomes in women with RIF after oocyte donation, is a possible component of the CODE protocol, but it cannot be considered a unique solution to RIF. This article reviews possible causes of RIF and places growth hormone treatment in the context of other important measures to be followed in the CODE protocol.

【 授权许可】

CC BY-NC